Analysis of the association between adverse events and outcome in patients receiving a programmed death protein-1 or programmed death ligand-1 antibody

Affiliations

¹ Research Unit, Hospital Costa del Sol, Marbella, Málaga, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), ISCIII, Madrid, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Surgery, Biochemistry and Immunology Department, School of Medicine, University of Málaga, Málaga, Spain.
² Research Unit, Hospital Costa del Sol, Marbella, Málaga, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), ISCIII, Madrid, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Surgery, Biochemistry and Immunology Department, School of Medicine, University of Málaga, Málaga, Spain. mredondo@hcs.es.

Free article

Comment

Marilina García-Aranda et al. Chin Clin Oncol. 2020 Aug.

Free article

. 2020 Aug;9(4):57.

doi: 10.21037/cco.2020.03.01. Epub 2020 Mar 4.

¹ Research Unit, Hospital Costa del Sol, Marbella, Málaga, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), ISCIII, Madrid, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Surgery, Biochemistry and Immunology Department, School of Medicine, University of Málaga, Málaga, Spain.
² Research Unit, Hospital Costa del Sol, Marbella, Málaga, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), ISCIII, Madrid, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Surgery, Biochemistry and Immunology Department, School of Medicine, University of Málaga, Málaga, Spain. mredondo@hcs.es.

No abstract available

Comment on

Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody.
Maher VE, Fernandes LL, Weinstock C, Tang S, Agarwal S, Brave M, Ning YM, Singh H, Suzman D, Xu J, Goldberg KB, Sridhara R, Ibrahim A, Theoret M, Beaver JA, Pazdur R. Maher VE, et al. J Clin Oncol. 2019 Oct 20;37(30):2730-2737. doi: 10.1200/JCO.19.00318. Epub 2019 May 22. J Clin Oncol. 2019. PMID: 31116675